Literature DB >> 28890826

Mutational burden on circulating cell-free tumor-DNA testing as a surrogate marker of mismatch repair deficiency or microsatellite instability in patients with colorectal cancers.

Pashtoon Murtaza Kasi1.   

Abstract

Entities:  

Year:  2017        PMID: 28890826      PMCID: PMC5582036          DOI: 10.21037/jgo.2017.06.05

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


× No keyword cloud information.
  3 in total

1.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

2.  Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.

Authors:  David S Hong; Van K Morris; Badi El Osta; Alexey V Sorokin; Filip Janku; Siqing Fu; Michael J Overman; Sarina Piha-Paul; Vivek Subbiah; Bryan Kee; Apostolia M Tsimberidou; David Fogelman; Jorge Bellido; Imad Shureiqi; Helen Huang; Johnique Atkins; Gabi Tarcic; Nicolas Sommer; Richard Lanman; Funda Meric-Bernstam; Scott Kopetz
Journal:  Cancer Discov       Date:  2016-10-11       Impact factor: 39.397

Review 3.  Acquired resistance to EGFR-targeted therapies in colorectal cancer.

Authors:  Beth O Van Emburgh; Andrea Sartore-Bianchi; Federica Di Nicolantonio; Salvatore Siena; Alberto Bardelli
Journal:  Mol Oncol       Date:  2014-05-14       Impact factor: 6.603

  3 in total
  5 in total

1.  Circulating tumor DNA and plasma microsatellite instability during PD-1 blockade.

Authors:  Pashtoon M Kasi
Journal:  J Gastrointest Oncol       Date:  2020-08

2.  Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas.

Authors:  Madiha Iqbal; Ali Roberts; Jason Starr; Kabir Mody; Pashtoon Murtaza Kasi
Journal:  J Gastrointest Oncol       Date:  2019-06

3.  Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction.

Authors:  Emmanuel Gabriel; Sanjay P Bagaria
Journal:  Front Oncol       Date:  2018-08-06       Impact factor: 6.244

4.  Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer.

Authors:  Farzaneh Rahvar; Mahdieh Salimi; Hossein Mozdarani
Journal:  Genet Mol Biol       Date:  2020-11-17       Impact factor: 1.771

Review 5.  Microsatellite Instability in Colorectal Cancer Liquid Biopsy-Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker.

Authors:  Francis Yew Fu Tieng; Nadiah Abu; Learn-Han Lee; Nurul-Syakima Ab Mutalib
Journal:  Diagnostics (Basel)       Date:  2021-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.